John Nuss

John Nuss

Chief Tech/Sci/R&D Officer at VENTYX BIOSCIENCES, INC.

Net worth: 1 M $ as of 2024-04-29

65 year
Health Technology
Consumer Services
Retail Trade

Profile

John M.
Nuss
is currently the Chief Scientific Officer at Escalier Biosciences BV, Ventyx Biosciences, Inc., and Vimalan Biosciences, Inc. He previously worked as the Senior Vice President-Chemistry at Exelixis, Inc. from 2000 to 2011 and as the Vice President-Drug Discovery at Ferring Research Institute, Inc. from 2012 to 2017.
Prior to his industry experience, he was an Assistant Professor-Chemistry at the University of California, Riverside.
Dr. Nuss holds a doctorate from the University of Wisconsin and an undergraduate degree from the University of Kansas.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-10 264,998 ( 0.45% ) 1 M $ 2024-04-29

John Nuss active positions

CompaniesPositionStart
VENTYX BIOSCIENCES, INC. Chief Tech/Sci/R&D Officer 2018-12-31
Chief Tech/Sci/R&D Officer 2016-12-31
Vimalan Biosciences, Inc. Chief Tech/Sci/R&D Officer 2017-09-30
All active positions of John Nuss

Former positions of John Nuss

CompaniesPositionEnd
Corporate Officer/Principal 2016-12-31
EXELIXIS, INC. Corporate Officer/Principal 2011-03-31
University of California, Riverside Corporate Officer/Principal -
See the detail of John Nuss's experience

Training of John Nuss

University of Wisconsin Doctorate Degree
University of Kansas Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Nuss's experience

Connections

60

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
EXELIXIS, INC.

Health Technology

VENTYX BIOSCIENCES, INC.

Health Technology

Private companies3

Health Technology

Vimalan Biosciences, Inc.

Retail Trade

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW